|
|
Article: Biotech Holdings closes additional private placement funding.
- Article from:
- PR Newswire
- Article date:
- February 27, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Robert Rieveley, President of Biotech Holdings (the "Company", TSX-VEN: BIO.V; OTC BB: BIOHF) said today that the Company has now closed an additional $159,639 of private placement funding announced January 27, 2004, bringing total funds received to $425,639.
"These funds are being applied to the completion of facilities improvements and machinery requirements at our new pre-mix facility for our diabetes drug, Sucanon, as well as to costs associated with the upcoming launch of Sucanon in Mexico and Peru and general corporate requirements," Mr. Rieveley said.
The total private placement funding that has now closed, including amounts reported February 3, ...